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Summary In a prospective study of 5,004 women in Guernsey, plasma samples were collected and stored.
Retinol, fl-carotene and vitamin E levels were later measured in the samples from 39 women who
subsequently developed breast cancer and from 78 controls who did not develop cancer. Plasma retinol levels
were not related to the risk of breast cancer, mean levels among cases and controls being 485jigl-1 and
479,igl 1 respectively. Plasma vitamin E levels showed a clear association, low levels being associated with a
significantly higher risk of cancer. The mean vitamin E levels among cases and controls were 4.7mgl-' and
6.0mgl-1 respectively (P<0.025), and the risk of breast cancer in women with vitamin E levels in the lowest
quintile was about 5-times higher than the risk for women with levels in the highest quintile (P<0.01). f,-
carotene levels showed a tendency to be lower in women who developed cancer than in controls (36ugl-1
among cases compared with 50pgI-1 among controls) but the difference was not statistically significant.
The view that certain vitamins, such as vitamin A
(in the form of retinol or its precursor f-carotene)
and vitamin E, may protect against the risk of
cancer has recently attracted much scientific
attention.
Three prospective studies, all concerning men,
have examined the relationship between serum
retinol and subsequent risk of cancer. Two of these
studies (Wald et al., 1980a,b; Kark et al., 1981)
showed a statistically significant negative
association between serum retinol and risk of
cancer (particularly lung cancer) and the third
(Stahelin et al., 1982) suggested a negative
association between serum retinol and risk of
stomach cancer. Studies investigating serum ,B-
carotene or serum vitamin E and subsequent risk of
cancer have not been published. Epidemiological
studies of diet and cancer are consistent with ,B-
carotene intake being associated with a reduced risk
of cancer (Peto et al., 1981: Shekelle et al., 1981)
but the evidence is relatively non-specific as dietary
factors other than #-carotene might well have been
involved. There is some evidence based on
experimental work on animals that both fl-carotene
(Mathews-Roth, 1982) and vitamin E (Cook &
McNamara, 1980) may protect against cancer and
both substances have antioxidant activity.
Further research is limited by the fact that there
are few large prospective epidemiological studies in
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which plasma samples have been stored for future
biochemical analysis. One such investigation is the
ICRF prospective study in Guernsey which has
been the subject of previous reports, mainly on the
role of endocrine factors in the aetiology of breast
cancer (Bulbrook et al., 1971; Kwa et al., 1981). The
availability of data and plasma samples from this
study encouraged us to explore the possibility that
low plasma concentrations of retinol, P-carotene
and vitamin E might be associated with subsequent
risk of breast cancer.
Materials and methods
Between 1968 and 1975, 5,004 women in Guernsey
aged between 28 and 75 years volunteered a blood
sample from which plasma was stored at -200C.
Women who developed breast cancer were notified
to the study by the general practitioners concerned,
and this report relates to the 39 cases reported until
the end of 1982 from whom plasma was available
for testing.
Stored plasma samples from these women were
retrieved and for each two controls who had
previously been used in a study of hormone levels
in relation to breast cancer were identified and their
plasma samples also retrieved. Selection of controls
in this way meant that plasma samples for cases
and controls had all been frozen and thawed a
similar number of times. The matching criteria were
age (± 5 years), menopausal status (if pre-
menopausal, day of menstrual cycle within 4 days;
if post-menopausal, number of years post-
menopausal), and a number of other factors
including parity, family history of breast cancer,
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and previous history of benign breast disease. The
plasma samples were measured for retinol, ,B-
carotene and vitamin E using high pressure liquid
chromatography as described for retinol assay
(Vuilleumier et al., 1983). This was done in
ignorance of their source (cases or controls).
Results
The mean plasma retinol, #-carotene and vitamin E
levels in cases and controls are shown in Table I,
according to the year blood was taken. The retinol
levels are similar among cases and controls and
appear to be unaffected by the duration of storage.
The f-carotene and vitamin E levels tend to be
lower among cases than among controls and show
a statistically significant decrease with increasing
duration of storage. Table II shows details of these
plasma levels according to the age of the woman
when the blood was taken. Among controls, all
three micronutrients increased with increasing age
Table I Mean (s.d.) plasma retinol, fl-carotene and vitamin E levels in breast cancer cases and
controls, according to duration of storage of samples
Year Blood Taken
1968-69 1970-71 1972-73 1974-75 x2for trend P-value
No. women
Cases 18 15 1 5
Controls 29 34 7 8
Retinol (pg1 1)
Cases 496 (144) 520 (116) 255 (-) 411 (172) 1.5393 NS
Controls 480 (128) 475 (136) 476 (86) 483 (93) 0.0000 NS
fl-carotene (pgI 1)
Cases 15 (13) 35 (59) 10 (-) 102 (113) 7.7323 <0.01
Controls 23 (36) 43 (43) 43 (32) 200 (150) 24.1914 <0.001
Vitamin E (mg1-1)
Cases 3.8 (1.7) 4.9 (2.1) 2.6 (-) 6.5 (4.7) 4.3571 <0.05
Controls 5.3 (2.5) 5.9 (2.9) 8.0 (4.8) 7.7 (2.8) 6.2831 <0.025
Table H Mean (s.d.) serum retinol, fl-carotene and vitamin E levels in
breast cancer cases and controls according to age of women
Age Group (years)
<45 45- 50- 55 or more
No. women
Cases 10 10 10 9
Controls 26 16 17 19
Retinol (gI1)
Cases 411 (118) 534 (166) 489 (114) 522 (150)
Controls 435 (111) 438 (104) 529 (113) 523 (139)
#-carotene (pg1 1)
Cases 14 (14) 53 (90) 48 (70) 14 (19)
Controls 37 (51) 66 (59) 81 (137) 34 (30)
Vitamin E (mg1 1)
Cases 3.4 (1.9) 5.3 (3.0) 4.9 (2.8) 4.6 (1.9)
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of the women up to age 50-54 years; thereafter
thl.c-c was t st .LMstion of dc (lcrease.
To allow for a declinc in the concentration of f-
carotenc and vitamin E levels in relation to
duration of storage of the plasma samples these
levels were, in subsequent analysis, standardised
(indirect method) for duration of storage using the
calendar year groups 1968, 1969-70, 1971 and later.
At the same time, since four controls fell outside
the 5-year age matching limits all the plasma levels
were standardised for the age of the women using
the age groups <45, 45-54, > 54 years.
Unstandardised and standardised mean plasma
levels of retinol, #-carotene and vitamin E are
shown in Table III according to the menopausal
status of the women at the time blood was taken.
All three micronutrients were lower in pre-
menopausal women than in post-menopausal
women; this difference was statistically significant
for retinol and f-carotene among controls
(P<0.025 and P<0.05 respectively). Overall,
vitamin E levels were statistically significantly lower
in cases than in controls (4.7mg1-1 compared with
6.0mg1- 1 [P<0.025]). fl-carotene levels were also
lower in cases than in controls (36pgl-' compared
with 56 pg1-), but the difference was not
statistically significant. Retinol levels were similar
among cases and controls (485 pgl- and 479 pgl-
respectively).
Table IV shows the relative risk of developing
cancer in relation to initial quintile of retinol, ,B-
carotene and vitamin E level, allowing for age, and,
for fl-carotene and vitamin E, also allowing for
duration of storage of plasma sample. Vitamin E
levels showed a statistically significant trend in risk
- those with the lowest vitamin E levels having the
highest risk of breast cancer. There was a
suggestion of a trend for fl-carotene, but this was
not statistically significant, and for retinol there was
no suggestion of any trend at all.
Discussion
In this study, plasma retinol levels were not related
to subsequent risk of breast cancer, whereas plasma
vitamin E levels showed a clear association (low
levels being associated with a significantly higher
risk of cancer). f-carotene levels showed a similar
tendency, but the effect was less strong and less
consistent.
The relationship between low plasma vitamin E
and #-carotene and a high incidence of breast
cancer may be a direct effect of these
micronutrients or may be due to other factors
which are themselves associated with vitamin E and
fl-carotene. The mean interval between sample
collection and diagnosis of breast cancer was 5
Table III Mean serum retinol, fl-carotene and vitamin E levels according to menopausal status at the time blood was
taken
Pre-Menopausal Post-Menapausal All
No. women
Cases 20 19 39
Controls 40 38 78
Standardised Standardised Standardised
Mean (s.d.) mean Mean (s.d.) mean Mean (s.d.) mean
Retinola (pIg 1 -1)
Cases 439 (107) 457 540 (156) 512 488 (141) 485
Controls 432 (102) 460c 525 (128) 497 478 (124) 479
/3-caroteneb (pugI 1)
Cases 20 (22) 22 47 (80) 49 34 (59) 36
Controls 43 (47) 38d 61 (100) 66 52 (78) 50
Vitamin Eb (mgI-1)
Cases 3.7 (1.9) 4.2e 5.4 (2.7) 5.1 4.5 (2.5) 4.7e
Controls 5.3 (2.0) 5.6 6.8 (3.7) 6.3 6.0 (3.0) 6.0
aIndirectly standardised for age of women.
bIndirectly standardised for age of women and duration of storage of serum samples.
cStatistically significantly lower than post-menopausal controls (P<0.025, randomisation test).
dStatistically significantly lower than post-menopausal controls (P<0.05, randomisation test).
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Table IV Relative risk (RR) of breast cancer according to quintiles of serum retinol, fl-carotene
and vitamin E
Retinola f-Caroteneb Vitamin Eb
No. of No. of No. of No. of No. of No. of
Quintilec cases controls RR cases controls RR cases controls RR
1st (lowest) 7 16 0.95 7 8 1.51 13 9 2.58
2nd 7 16 0.89 10 18 1.01 8 15 0.92
3rd 6 17 0.71 8 14 1.30 5 19 0.52
4th 12 12 1.86 8 13 1.15 5 19 0.52
5th (highest) 7 17 0.80 6 25 0.54 4 19 0.50
All 39 78 1.00 39 78 1.00 39 78 1.00
2~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
xi for trend 0.0443 2.3909 9.9370
P-value NS NS <0.01
aAdjusted for age of women.
bAdjusted for age of women and duration of storage of serum samples.
CQuintile limits, lowest to highest, were: Retinol, 202-, 380-, 433-, 500-, 567-961 ,gI -
fl-carotene, 0, 10, 20, 30-40, 50-480MgI-1.
Vitamin E, 0.1-, 3.3-, 4.6-, 5.9-, 7.7-17.5mg1I.
years. For all but 6 cases the interval was 2 or
more years. The long interval between the time
when the blood samples were collected and when
breast cancer was diagnosed (5-years on average)
makes it unlikely that the cancer caused the lower
levels of these micronutrients. Similar results were
found after excluding women who were diagnosed
within 2 years of the blood sample being collected.
After such exclusions the standardised mean vitamin
E level for cases was 4.4mg11 compared with
5.9mgI-1 for controls (P<O.O1), and the
corresponding values for fl-carotene were 29jugl-
and 50pgI1-.
Plasma fl-carotene levels are known to be
associated with diet, particularly the consumption
of vegetables. The determinants of plasma vitamin
E are less well known, but appear to include
dietary factors. Vitamin E is present in many plants
including lettuce, grasses, peanuts and seeds, the
highest levels being associated with seed oil.
Whatever the precise role of f-carotene or
vitamin E in the aetiology of breast cancer, these
findings may provide clues which help identify
causes of breast cancer and thereby provide an
opportunity of exploring ways of preventing the
disease.
We thank Dr R.M. Salkeld and Dr J.P. Vuilleumier of
Hoffman La Roche, Basle, for the serum retinol fB-carotine
and vitamin E estimations.
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